Bioprinting Studies How Cancer Cells Grow and Spread
By LabMedica International staff writers Posted on 26 Feb 2019 |
Image: Researchers found that cells behave differently in this three-dimensional (3D) soft tissue environment than on two-dimensional (2D) plastic or glass surfaces (Photo courtesy of the University of Minnesota).
Novel use of a three-dimensional (3D) bioprinting technique has created new ways to study how cancer cells grow and spread.
Investigators at the University of Minnesota (Minneapolis/St. Paul, USA) have developed three-dimensional bioprinting techniques that have been adapted to build tumor constructs via precise placement of living cells, functional biomaterials, and programmable release capsules.
Three-dimensional bioprinting combines cells, growth factors, and biomaterials to fabricate biomedical constructs that maximally imitate natural tissue characteristics. Generally, three-dimensional bioprinting utilizes the layer-by-layer method to deposit biological materials to create tissue-like structures. Emerging innovations include bioprinting of cells or extracellular matrix deposited into a three-dimensional gel layer by layer to produce the desired tissue or organ.
The technique described in the January 21, 2019, online edition of the journal Advanced Materials enabled the spatiotemporal control of signaling molecular gradients, thereby dynamically modulating cellular behaviors at a local level.
Vascularized tumor models were created to mimic key steps of cancer dissemination (invasion, intravasation, and angiogenesis), based on guided migration of tumor cells and endothelial cells in the context of stromal cells and growth factors. In addition, the investigators described the benefits of using these metastatic models for drug screening by evaluating the anticancer efficacy of immunotoxins.
“This model is more consistent with what the body is like,” said senior author Dr. Angela Panoskaltsis-Mortari, professor of pediatrics at the University of Minnesota, “and, therefore, studying the effects of drugs with human cells at this level makes the results more meaningful and predictive of what will happen in the body.”
Related Links:
University of Minnesota
Investigators at the University of Minnesota (Minneapolis/St. Paul, USA) have developed three-dimensional bioprinting techniques that have been adapted to build tumor constructs via precise placement of living cells, functional biomaterials, and programmable release capsules.
Three-dimensional bioprinting combines cells, growth factors, and biomaterials to fabricate biomedical constructs that maximally imitate natural tissue characteristics. Generally, three-dimensional bioprinting utilizes the layer-by-layer method to deposit biological materials to create tissue-like structures. Emerging innovations include bioprinting of cells or extracellular matrix deposited into a three-dimensional gel layer by layer to produce the desired tissue or organ.
The technique described in the January 21, 2019, online edition of the journal Advanced Materials enabled the spatiotemporal control of signaling molecular gradients, thereby dynamically modulating cellular behaviors at a local level.
Vascularized tumor models were created to mimic key steps of cancer dissemination (invasion, intravasation, and angiogenesis), based on guided migration of tumor cells and endothelial cells in the context of stromal cells and growth factors. In addition, the investigators described the benefits of using these metastatic models for drug screening by evaluating the anticancer efficacy of immunotoxins.
“This model is more consistent with what the body is like,” said senior author Dr. Angela Panoskaltsis-Mortari, professor of pediatrics at the University of Minnesota, “and, therefore, studying the effects of drugs with human cells at this level makes the results more meaningful and predictive of what will happen in the body.”
Related Links:
University of Minnesota
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples